The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Open accessAbstract
Peptide therapeutics have played a notable role in medical practice since the advent of insulin therapy in the 1920s. Over 60 peptide drugs are approved in the United States and other major markets, and peptides continue to enter clinical development at a steady pace. Peptide drug discovery has diversified beyond its traditional focus on endogenous human peptides to include a broader range of structures identified from other natural sources or through medicinal chemistry efforts. We maintain a comprehensive dataset on peptides that have entered human clinical studies that includes over 150 peptides in active development today. Here we provide an overview of the peptide therapeutic landscape, including historical perspectives, molecular characteristics, regulatory benchmarks, and a therapeutic area breakdown.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Peptides (2–50 amino acids) and proteins (more than 50 amino acids) have better selectivity for human specific targets. The larger molecular size and diverse quaternary structure enhance their interaction with specific protein pockets, making peptides and protein drugs have better biological activity and lower toxicity than small molecules.294,295”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [294]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Müller, A., Schäberle, T. F., Hughes, D. E., Epstein, S. S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.esgl · Cited by 1,140
Stupp, R., Hegi, M. E., Gorlia, T., Erridge, S. C., Perry, J., Hong, Y.-K., Aldape, K. D., Lhermitte, B., Pietsch, T., Grujicic, D., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70379-1 · Cited by 1,052
Advances in Fmoc solid‐phase peptide synthesis
Behrendt, R., White, P., & Offer, J. (2016) · Journal of Peptide Science · doi:10.1002/psc.2836 · Cited by 767
(1922) · PubMed · Cited by 753
Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
Finan, B., Ma, T., Ottaway, N., Müller, T. D., Habegger, K. M., Heppner, K. M., Kirchner, H., Holland, J., Hembree, J., Raver, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007218 · Cited by 696
Chang, Y. S., Graves, B. J., Guerlavais, V., Tovar, C., Packman, K. E., To, K.-H., Olson, K. A., Kesavan, K. P., Gangurde, P., Mukherjee, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303002110 · Cited by 681
Strategic Approaches to Optimizing Peptide ADME Properties
Di, L. (2015) · The AAPS Journal · doi:10.1208/s12248-014-9687-3 · Cited by 669
Large-scale manufacture of peptide therapeutics by chemical synthesis
Bray, B. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1133 · Cited by 601
Asprosin, a Fasting-Induced Glucogenic Protein Hormone
Romere, C., Duerrschmid, C., Bournat, J., Constable, P., Jain, M., Xia, F., Saha, P. K., Del Solar, M., Zhu, B., York, B., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.063 · Cited by 591
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 1,001
Amino-Acid-Conjugated Natural Compounds: Aims, Designs and Results
Arifian, H., Maharani, R., Megantara, S., Gazzali, A. M., & Muchtaridi, M. (2022) · Molecules · doi:10.3390/molecules27217631 · Cited by 46
Wu, X., Lin, H., Bai, R., & Duan, H. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116262 · Cited by 52
Tackling Undruggable Targets with Designer Peptidomimetics and Synthetic Biologics
Swenson, C., Mandava, G., Thomas, D. M., & Moellering, R. E. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00423 · Cited by 55
Cancer-Targeted Delivery Systems Based on Peptides
Chatzisideri, T., Leonidis, G., & Sarli, V. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0174 · Cited by 46
Vogt, E., & Künzler, M. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-09893-x · Cited by 45
Targeted and MMP-2/9 responsive peptides for the treatment of rheumatoid arthritis
Li, N., Qiao, Y., Xue, L., Xu, S., & Zhang, N. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118625 · Cited by 45
Bioactive Peptides as Therapeutic Adjuvants for Cancer
Bojórquez, N. D. C. Q., & Campos, M. R. S. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2020.1813316 · Cited by 45
Stauber, J. M., Rheingold, A. L., & Spokoyny, A. M. (2021) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.1c00087 · Cited by 46
Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases
Onyango, I. G., Bennett, J. P., & Stokin, G. B. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.303007 · Cited by 45
Design of Protein Segments and Peptides for Binding to Protein Targets
Gupta, S., Azadvari, N., & Hosseinzadeh, P. (2022) · BioDesign Research · doi:10.34133/2022/9783197 · Cited by 47
2024 FDA TIDES (Peptides and Oligonucleotides) Harvest
Musaimi, O. A., Shaer, D. A., de la Torre, B. G., & Alberício, F. (2025) · Pharmaceuticals · doi:10.3390/ph18030291 · Cited by 45
Recent Advances in Peptide-Based Approaches for Cancer Treatment
Conibear, A. C., Schmid, A., Kamalov, M., Becker, C. F. W., & Bello, C. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867325666171123204851 · Cited by 44
Peptide-Based Therapeutics for Oncology
Fisher, E. N., Pavlenko, K. A., Vlasov, A. M., & Ramenskaya, G. V. (2019) · Pharmaceutical Medicine · doi:10.1007/s40290-018-0261-7 · Cited by 45
O-GlcNAc Engineering of GPCR Peptide-Agonists Improves Their Stability and in Vivo Activity
Levine, P. M., Balana, A. T., Sturchler, E., Koole, C., Noda, H., Zarzycka, B. A., Daley, E. J., Truong, T. T., Katritch, V., Gardella, T. J., et al. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b05365 · Cited by 44
Astrocytic Connexin43 Channels as Candidate Targets in Epilepsy Treatment
Walrave, L., Vinken, M., Leybaert, L., & Smolders, I. J. (2020) · Biomolecules · doi:10.3390/biom10111578 · Cited by 44
Taleb, M., Atabakhshi‐Kashi, M., Wang, Y., Alanagh, H. R., Sabet, Z. F., Li, F., Cheng, K., Li, C., Qi, Y., Nie, G., et al. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100051 · Cited by 44
Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery
Domingues, I., Leclercq, I. A., & Beloqui, A. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.040 · Cited by 45
Hydrogels For Peptide Hormones Delivery: Therapeutic And Tissue Engineering Applications
Doostmohammadi, M., Ameri, A., Mohammadinejad, R., Noudeh, N. D., Banat, I. M., Ohadi, M., & Dehghannoudeh, G. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s217211 · Cited by 43
Synthetic molecular evolution of antimicrobial peptides
Chen, C. H., Bepler, T., Pepper, K., Fu, D., & Lu, T. K. (2022) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2022.102718 · Cited by 43
Cyclization and Docking Protocol for Cyclic Peptide–Protein Modeling Using HADDOCK2.4
Charitou, V., van Keulen, S. C., & Bonvin, A. M. J. J. (2022) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.2c00075 · Cited by 43
Bicyclic peptides: Paving the road for therapeutics of the future
Ullrich, S., & Nitsche, C. (2023) · Peptide Science · doi:10.1002/pep2.24326 · Cited by 42
Peptide-nanoparticle conjugates as a theranostic platform
Kim, S., No, Y. H., Sluyter, R., Konstantinov, K., Kim, J. H., & Kim, J. H. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215530 · Cited by 46
Cao, L., Xu, Z., Shang, T., Zhang, C., Wu, X., Wu, Y., Zhai, S., Zhan, Z., & Duan, H. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01611 · Cited by 55
Epimerization-Free C-Term Activation of Peptide Fragments by Ball Milling
Yeboue, Y., Jean, M., Subra, G., Martínez, J., Lamaty, F., & Métro, T. (2021) · Organic Letters · doi:10.1021/acs.orglett.0c03209 · Cited by 42
Biomedical applications of the peptide decorated gold nanoparticles
Rai, A., & Ferreira, L. (2021) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2020.1853031 · Cited by 42
Purushothaman, M., Sarkar, S., Morita, M., Gugger, M. F., Schmidt, E. W., & Morinaka, B. I. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202015975 · Cited by 42
TRP Channels Interactome as a Novel Therapeutic Target in Breast Cancer
Saldías, M. P., Maureira, D., Orellana‐Serradell, O., Silva, I., Lavanderos, B. J., Cruz, P., Torres, C., Cáceres, M., & Cerda, O. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.621614 · Cited by 46
Visible‐Light Mediated Tryptophan Modification in Oligopeptides Employing Acylsilanes
Reimler, J., & Studer, A. (2021) · Chemistry - A European Journal · doi:10.1002/chem.202102749 · Cited by 42
Development and Regulatory Challenges for Peptide Therapeutics
Zane, D., Feldman, P. L., Sawyer, T. K., Sobol, Z., & Hawes, J. J. (2020) · International Journal of Toxicology · doi:10.1177/1091581820977846 · Cited by 42
Staby, A., Steensgaard, D. B., Haselmann, K. F., Marino, J. S., Bartholdy, C., Videbæk, N., Schelde, O., Bosch‐Traberg, H., Spang, L. T., & Asgreen, D. J. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-02817-9 · Cited by 40
Grønning, A. G. B., Kacprowski, T., & Scheele, C. C. (2021) · Biology Methods and Protocols · doi:10.1093/biomethods/bpab021 · Cited by 41
Emerging Pharmacotherapeutic Strategies to Overcome Undruggable Proteins in Cancer
Lu, Y., Yang, Y., Zhu, G., Zeng, H., Fan, Y., Guo, F., Xu, D., Wang, B., Chen, D., & Ge, G. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.83026 · Cited by 42
Chamieh, J., Tarrat, A. D., Doudou, C., Jannin, V., Demarne, F., & Cottet, H. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.039 · Cited by 41
Solid‐Phase Total Synthesis of Yaku'amide B Enabled by Traceless Staudinger Ligation
Itoh, H., Miura, K., Kamiya, K., Yamashita, T., & Inoue, M. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201916517 · Cited by 41
Natural and grafted cyclotides in cancer therapy: An insight
Mehta, L., Dhankhar, R., Gulati, P., Kapoor, R. K., Mohanty, A., & Kumar, S. (2020) · Journal of Peptide Science · doi:10.1002/psc.3246 · Cited by 41
Plant Bioactive Peptides: Current Status and Prospects Towards Use on Human Health
Chai, T., Ee, K. Y., Kumar, D. T., Manan, F. A., & Wong, F. (2020) · Protein and Peptide Letters · doi:10.2174/0929866527999201211195936 · Cited by 42
Ocular Delivery of Therapeutic Agents by Cell-Penetrating Peptides
Nhàn, N. T. T., Maidana, D. E., & Yamada, K. H. (2023) · Cells · doi:10.3390/cells12071071 · Cited by 40
Perspectives in Searching Antimicrobial Peptides (AMPs) Produced by the Microbiota
Gallardo-Becerra, L., Cervantes-Echeverría, M., Cornejo‐Granados, F., Vazquez-Morado, L. E., & Ochoa‐Leyva, A. (2023) · Microbial Ecology · doi:10.1007/s00248-023-02313-8 · Cited by 41
Kao, C., Chandna, R., Ghode, A., D’Souza, C., Chen, M., Larsson, A., Lim, S. H., Wang, M., Cao, Z., Zhu, Y. Z., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.06.004 · Cited by 40
The Untapped Pharmacopeic Potential of Helminths
Janina, K., Brattig, N. W., & Liebau, E. (2018) · Trends in Parasitology · doi:10.1016/j.pt.2018.05.011 · Cited by 41
Proteasome Activation to Combat Proteotoxicity
Jones, C. L., & Tepe, J. J. (2019) · Molecules · doi:10.3390/molecules24152841 · Cited by 43
Pourahadi, A., Nojavan, S., & Davarani, S. S. H. (2020) · Talanta · doi:10.1016/j.talanta.2020.121025 · Cited by 40
Quantitative measurement of cytosolic penetration using the chloroalkane penetration assay
Deprey, K. L., & Kritzer, J. A. (2020) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2020.03.003 · Cited by 39
Homing Peptides for Cancer Therapy
Lingasamy, P., & Teesalu, T. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-58174-9_2 · Cited by 42
Monti, A., Vitagliano, L., Caporale, A., Ruvo, M., & Doti, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097842 · Cited by 43
Design and Synthesis of A PD-1 Binding Peptide and Evaluation of Its Anti-Tumor Activity
Abbas, A. B., Lin, B., Liu, C., Morshed, A., Hu, J., & Xu, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030572 · Cited by 39
Peptide Antiviral Strategies as an Alternative to Treat Lower Respiratory Viral Infections
Nyanguile, O. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01366 · Cited by 39
The anti‐ageing effects of a natural peptide discovered by artificial intelligence
Kennedy, K., Cal, R., Casey, R., Lopez, C., Adelfio, A., Molloy, B., Wall, A. M., Holton, T. A., & Khaldi, N. (2020) · International Journal of Cosmetic Science · doi:10.1111/ics.12635 · Cited by 39
Cavaco, M. C., Pérez‐Peinado, C., Valle, J., Silva, R. D. M., Correia, J. D. G., Andreu, D., Castanho, M. A. R. B., & Neves, V. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.552035 · Cited by 39
Oral delivery of peptide therapeutics in infants: Challenges and opportunities
Gleeson, J. P., Fein, K. C., & Whitehead, K. A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.011 · Cited by 39
The role of peptide-based therapeutics in oncotherapy
Timur, S. S., & Gürsoy, R. N. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.1906884 · Cited by 40
Slezina, M. P., & Odintsova, T. I. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45040239 · Cited by 39
Venanzi, M., Savioli, M., Cimino, R., Gatto, E., Palleschi, A., Ripani, G., Cicero, D. O., Placidi, E., Orvieto, F., & Bianchi, E. (2020) · Soft Matter · doi:10.1039/d0sm01011a · Cited by 40
Harnessing molecular recognition for localized drug delivery
Liu, R., Zuo, R., & Hudalla, G. A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.008 · Cited by 37
Replacing piperidine in solid phase peptide synthesis: effective Fmoc removal by alternative bases
Martelli, G., Cantelmi, P., Palladino, C., Mattellone, A., Corbisiero, D., Fantoni, T., Tolomelli, A., Macis, M., Ricci, A., Cabri, W., et al. (2021) · Green Chemistry · doi:10.1039/d1gc02634h · Cited by 40
Self-assembling peptides as immunomodulatory biomaterials
Hernández, A., Hartgerink, J. D., & Young, S. W. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1139782 · Cited by 39
Chintamaneni, P. K., Pindiprolu, S. K. S. S., Swain, S. S., Karri, V. V. S. R., Nesamony, J., Selvam, C., & Bhaskaran, M. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216782 · Cited by 38
Organoboron catalysis for direct amide/peptide bond formation
Koshizuka, M., Takahashi, N., & Shimada, N. (2024) · Chemical Communications · doi:10.1039/d4cc02994a · Cited by 38
Bio-nanomaterials: Promising anticancer properties and treatment strategies
Elemike, E. E., Onunkwo, I. C., Ughumiakpor, O., Alawuru, F., Mukoro, A., Ishom, P., Obarakpor, F., Hossain, I., & Aziza, A. E. (2025) · Nano TransMed · doi:10.1016/j.ntm.2025.100076 · Cited by 42
Peptides as epigenetic modulators: therapeutic implications
Janssens, Y., Wynendaele, E., Berghe, W. V., & Spiegeleer, B. M. J. D. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0700-7 · Cited by 37
Terrey, M. J., Holmes, A., Perry, C. C., & Cross, W. B. (2019) · Organic Letters · doi:10.1021/acs.orglett.9b02894 · Cited by 38
Tian, R., Zhu, L., Qin, Z., Wang, G., Wang, J., & Zhang, H. (2019) · Biomaterials Science · doi:10.1039/c9bm01248f · Cited by 39
Advantageous use of SFC for separation of crude therapeutic peptides and peptide libraries
Ventura, M. C. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113227 · Cited by 38
Macrocyclization of an all- d linear α-helical peptide imparts cellular permeability
Kannan, S., Aronica, P. G. A., Ng, S., Lian, D. T. G., Frosi, Y., Chee, S. M. Q., Jiang, S., Yuen, T. Y., Sadruddin, A., Kaan, H. Y. K., et al. (2020) · Chemical Science · doi:10.1039/c9sc06383h · Cited by 38
Conner, K. P., Devanaboyina, S. C., Thomas, V. A., & Rock, D. A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107574 · Cited by 39
Denning, N., Aziz, M., Ochani, M., Prince, J. M., & Wang, P. (2020) · Surgery · doi:10.1016/j.surg.2020.04.010 · Cited by 38
Peptides that immunoactivate the tumor microenvironment
Furukawa, N., & Popel, A. S. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188486 · Cited by 39
Abeer, M. M., Trajkovic, S., & Brayden, D. J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112275 · Cited by 40
Inhibition of Viral Membrane Fusion by Peptides and Approaches to Peptide Design
Düzgüneş, N., Fernández‐Fuentes, N., & Konopka, K. (2021) · Pathogens · doi:10.3390/pathogens10121599 · Cited by 38
Tyrosine bioconjugation with hypervalent iodine
Declas, N., Maynard, J. R. J., Menin, L., Gasilova, N., Götze, S., Sprague, J. L., Stallforth, P., Matile, S., & Waser, J. (2022) · Chemical Science · doi:10.1039/d2sc04558c · Cited by 38
Gattu, R., Ramesh, S. S., Nadigar, S., Channe Gowda, D., & Ramesh, S. (2023) · Antibiotics · doi:10.3390/antibiotics12030532 · Cited by 40
The Beneficial Effects of Soybean Proteins and Peptides on Chronic Diseases
Hu, S., Liu, C., & Liu, X. (2023) · Nutrients · doi:10.3390/nu15081811 · Cited by 40
Design of a substrate-tailored peptiligase variant for the efficient synthesis of thymosin-α 1
Schmidt, M., Toplak, A., Rozeboom, H. J., Wijma, H. J., Quaedflieg, P. J. L. M., van Maarseveen, J. H., Janssen, D. B., & Nuijens, T. (2018) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob02812a · Cited by 37
Wibel, R., Friedl, J. D., Zaichik, S., & Bernkop‐Schnürch, A. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.04.004 · Cited by 37
Harnessing cyclotides to design and develop novel peptide GPCR ligands
Muratspahić, E., Koehbach, J., Gruber, C. W., & Craik, D. J. (2020) · RSC Chemical Biology · doi:10.1039/d0cb00062k · Cited by 36
Amphiphilic Iodine(III) Reagents for the Lipophilization of Peptides in Water
Mishra, A. K., Tessier, R., Hari, D. P., & Waser, J. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202106458 · Cited by 37
Asymmetric biomimetic transamination of α-keto amides to peptides
Cai, W., Qiao, X., Zhang, H., Li, B., Guo, J., Zhang, L., Chen, W., & Zhao, B. (2021) · Nature Communications · doi:10.1038/s41467-021-25449-y · Cited by 37
Intestinal permeation enhancers enable oral delivery of macromolecules up to 70 kDa in size
Fein, K. C., Gleeson, J. P., Newby, A. N., & Whitehead, K. A. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.11.010 · Cited by 37
Ye, J., Li, A., Zheng, H., Yang, B., & Lu, Y. (2023) · Advanced Biology · doi:10.1002/adbi.202200232 · Cited by 37
Side-Selective Solid-Phase Metallaphotoredox N(in)-Arylation of Peptides
Delgado, J. A. C., Tian, Y., Marcon, M., König, B., & Paixão, M. W. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c10792 · Cited by 36
Chandra, A. A., Sharma, A. K., Dehzangi, A., Tsunoda, T., & Sattar, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-47624-5 · Cited by 38
Kumar, A., Sharma, A., de la Torre, B. G., & Alberício, F. (2019) · Molecules · doi:10.3390/molecules24214004 · Cited by 36
de la Torre, B. G., Kumar, A., Alhassan, M., Bucher, C., Alberício, F., & Lopez, J. C. (2020) · Green Chemistry · doi:10.1039/c9gc03784e · Cited by 36
Artificial chaperones: From materials designs to applications
Hanpanich, O., & Maruyama, A. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120150 · Cited by 36
Insights into Fast Amide Couplings in Aqueous Nanomicelles
Sharma, S., Kaur, G., & Handa, S. (2021) · Organic Process Research & Development · doi:10.1021/acs.oprd.1c00203 · Cited by 37
Late-Stage C–H Acylation of Tyrosine-Containing Oligopeptides with Alcohols
Urruzuno, I., Andrade‐Sampedro, P., & Correa, A. (2021) · Organic Letters · doi:10.1021/acs.orglett.1c02764 · Cited by 36
Therapeutic Potential of Antimicrobial Peptides for Wound Healing
Nasseri, S., & Sharifi, M. (2022) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-021-10350-5 · Cited by 36
Peptide Self-Assembled Nanostructures: From Models to Therapeutic Peptides
Gatto, E., Toniolo, C., & Venanzi, M. (2022) · Nanomaterials · doi:10.3390/nano12030466 · Cited by 36
Assemblies of Peptides in a Complex Environment and their Applications
Wang, H., Feng, Z., & Xu, B. (2019) · Angewandte Chemie · doi:10.1002/ange.201814552 · Cited by 36
How can we improve peptide drug discovery? Learning from the past
Craik, D. J., & Kan, M. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1961740 · Cited by 36
Bothe, J. R., Andrews, A., Smith, K. J., Joyce, L. A., Krishnamachari, Y., & Kashi, S. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00106 · Cited by 35
Bimodal liquid biopsy for cancer immunotherapy based on peptide engineering and nanoscale analysis
Bu, J., Jeong, W.-J., Jafari, R., Kubiatowicz, L. J., Nair, A., Poellmann, M. J., Hong, R. S., Liu, E. W., Owen, R. H., Rawding, P. A., et al. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114445 · Cited by 35
A simple method for developing lysine targeted covalent protein reagents
Gabizon, R., Tivon, B., Reddi, R. N., van den Oetelaar, M. C. M., Amartely, H., Cossar, P. J., Ottmann, C., & London, N. (2023) · Nature Communications · doi:10.1038/s41467-023-42632-5 · Cited by 37
Ilieş, B. D., Yıldız, İ., & Abbas, M. (2024) · ChemBioChem · doi:10.1002/cbic.202300867 · Cited by 38
A journey through the emergence of nanomedicines with poly(alkylcyanoacrylate) based nanoparticles
Vauthier, C. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1588280 · Cited by 37
Targeting PCNA with Peptide Mimetics for Therapeutic Purposes
Horsfall, A. J., Abell, A. D., & Bruning, J. B. (2019) · ChemBioChem · doi:10.1002/cbic.201900275 · Cited by 35
Understanding Peptide Binding in Class A G Protein-Coupled Receptors
Tikhonova, I. G., Gigoux, V., & Fourmy, D. (2019) · Molecular Pharmacology · doi:10.1124/mol.119.115915 · Cited by 34
Trends in Therapeutic Conjugates: Bench to Clinic
Rudra, A., Li, J., Shakur, R., Bhagchandani, S. H., & Langer, R. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00828 · Cited by 36
Site-selective aqueous C–H acylation of tyrosine-containing oligopeptides with aldehydes
Segundo, M. S., & Correa, A. (2020) · Chemical Science · doi:10.1039/d0sc03791e · Cited by 35
Cyclisation strategies for stabilising peptides with irregular conformations
Vu, Q. N., Young, R., Sudhakar, H. K., Gao, T., Huang, T., Tan, Y. S., & Lau, Y. H. (2021) · RSC Medicinal Chemistry · doi:10.1039/d1md00098e · Cited by 35
Metadata
- Authors
- Lau, J. L., & Dunn, M. K.
- Affiliations
- Ferring Research Institute (United States) (US)
- Corresponding author
- Dunn, Michael K.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 26
- Issue
- 10
- Pages
- 2700-2707
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W2724823461
- Cited by
- 1,879
- References
- 44
- Citations by year
- 2026: 146 · 2025: 179 · 2024: 205 · 2023: 236 · 2022: 299 · 2021: 275 · 2020: 278 · 2019: 194 · 2018: 59
- FWCI
- 13.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Bioorganic & Medicinal Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- peptide therapeutics, peptide drug discovery, clinical development, insulin, therapeutic areas
- MeSH terms
- Animals, Drug Evaluation, Humans, Peptides, Drug Approval, Drug Discovery, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review